This company is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Tricida Gestion
Gestion contrôle des critères 3/4
Tricida's CEO is Gerrit Klaerner, appointed in Aug 2013, they has a tenure of 9.83 years. Their total yearly compensation is $4.68M , comprised of 12.8% salary and 87.2% bonuses, including company stock and options. They directly owns 0.68% of the company’s shares, worth $3.93. The average tenure of the management team and the board of directors is 4 years and 9.5 years respectively.
Informations clés
Gerrit Klaerner
Directeur général
US$4.7m
Rémunération totale
Pourcentage du salaire du PDG | 12.8% |
Durée du mandat du directeur général | 9.8yrs |
Propriété du PDG | 0.7% |
Durée moyenne d'occupation des postes de direction | 4yrs |
Durée moyenne du mandat des membres du conseil d'administration | 9.5yrs |
Mises à jour récentes de la gestion
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$134m |
Jun 30 2022 | n/a | n/a | -US$148m |
Mar 31 2022 | n/a | n/a | -US$153m |
Dec 31 2021 | US$5m | US$600k | -US$177m |
Sep 30 2021 | n/a | n/a | -US$181m |
Jun 30 2021 | n/a | n/a | -US$219m |
Mar 31 2021 | n/a | n/a | -US$244m |
Dec 31 2020 | US$9m | US$598k | -US$265m |
Sep 30 2020 | n/a | n/a | -US$268m |
Jun 30 2020 | n/a | n/a | -US$235m |
Mar 31 2020 | n/a | n/a | -US$213m |
Dec 31 2019 | US$10m | US$584k | -US$177m |
Sep 30 2019 | n/a | n/a | -US$146m |
Jun 30 2019 | n/a | n/a | -US$131m |
Mar 31 2019 | n/a | n/a | -US$120m |
Dec 31 2018 | US$1m | US$503k | -US$103m |
Sep 30 2018 | n/a | n/a | -US$96m |
Jun 30 2018 | n/a | n/a | -US$77m |
Mar 31 2018 | n/a | n/a | -US$60m |
Dec 31 2017 | US$821k | US$425k | -US$41m |
Rémunération vs marché: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the US market ($USD747.42K).
Rémunération et revenus: Gerrit's compensation has been consistent with company performance over the past year.
PDG
Gerrit Klaerner (51 yo)
9.8yrs
Titularisation
US$4,676,490
Compensation
Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Founder | 9.8yrs | US$4.68m | 0.68% $ 3.9 | |
COO, CFO & Executive VP | 6.2yrs | US$2.51m | 0.72% $ 4.2 | |
Executive VP | 3.3yrs | US$2.43m | 0.031% $ 0.2 | |
Executive Vice President of Clinical Development | 4.8yrs | US$2.77m | 0.0060% $ 0.03 | |
VP of Finance & Chief Accounting Officer | 2.5yrs | pas de données | pas de données | |
Vice President of Investor Relations & Communications | no data | pas de données | pas de données | |
Executive Vice President of Intellectual Property | 3.3yrs | US$2.10m | pas de données |
4.0yrs
Durée moyenne de l'emploi
58yo
Âge moyen
Gestion expérimentée: TCDA.Q's management team is considered experienced (4 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Founder | 9.9yrs | US$4.68m | 0.68% $ 3.9 | |
Independent Non-Employee Director | 5.1yrs | US$329.00k | 0.074% $ 0.4 | |
Independent Chairman of the Board | 9.3yrs | US$379.00k | 0.20% $ 1.1 | |
Independent Non-Employee Director | 6.9yrs | US$326.50k | 0.019% $ 0.1 | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.7yrs | US$314.00k | pas de données | |
Member of Scientific & Clinical Advisory Board | no data | pas de données | pas de données | |
Member of Scientific & Clinical Advisory Board | no data | pas de données | pas de données | |
Member of Scientific & Clinical Advisory Board | no data | pas de données | pas de données | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.9yrs | US$316.50k | 0.15% $ 0.9 | |
Member of Scientific & Clinical Advisory Board | no data | pas de données | pas de données | |
Member of Scientific & Clinical Advisory Board | no data | pas de données | pas de données | |
Member of Scientific and Clinical Advisory Board | no data | pas de données | pas de données |
9.5yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Conseil d'administration expérimenté: TCDA.Q's board of directors are considered experienced (9.5 years average tenure).